Mefruside

Clinical data
AHFS/Drugs.com	International Drug Names
Routes of administration	Oral
ATC code	C03BA05 (WHO)
Legal status
Legal status	In general: ℞ (Prescription only)
Identifiers
IUPAC name 4-chloro-N1-methyl-N1-[(2-methyltetrahydrofuran-2-yl)methyl]benzene-1,3-disulfonamide
CAS Number	7195-27-9 Y
PubChem CID	4047
ChemSpider	3907 N
UNII	X1NS9SNS92
KEGG	D01877 Y
CompTox Dashboard (EPA)	DTXSID0048844
ECHA InfoCard	100.027.785
Chemical and physical data
Formula	C13H19ClN2O5S2
Molar mass	382.87 g·mol−1
3D model (JSmol)	Interactive image
SMILES CC1(CCCO1)CN(C)S(=O)(=O)C2=CC(=C(C=C2)Cl)S(=O)(=O)N
InChI InChI=1S/C13H19ClN2O5S2/c1-13(6-3-7-21-13)9-16(2)23(19,20)10-4-5-11(14)12(8-10)22(15,17)18/h4-5,8H,3,6-7,9H2,1-2H3,(H2,15,17,18) N Key:SMNOERSLNYGGOU-UHFFFAOYSA-N N
NY (what is this?)  (verify)

Mefruside (INN) is a diuretic indicated for the treatment of edema and hypertension.^[1]

It was developed by Bayer A.G. and is sold under the tradename Baycaron.